Thanks again SB. Were you happy with your final procedure outcome and importantly would you recommend it to others.
Licensing of Ortho ATI/ACI would seem the way to go and if the company ultimately fire up in big markets such as USA/EU it is reasonable to assume that there will be a need for multiple manufacturing lab sites.
Stem Cell Therapy advancements, page-469
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
0.015(3.33%) |
Mkt cap ! $96.40M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 46.5¢ | 45.0¢ | $73.96K | 163.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6949 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 73825 | 7 |
View Market Depth
| Last trade - 14.48pm 16/09/2024 (20 minute delay) ? |
| OCC (ASX) Chart |